3D Hydrogel Biochips Help Detect Bowel Cancer
By HospiMedica International staff writers Posted on 06 Jun 2016 |
Image: The hydrogel-based biochip to help detect bowel cancer (Photo courtesy of MIPT.)
A novel three-dimensional (3D) hydrogel-based biochip containing molecular probes can help detect serological signatures in the sera of colorectal cancer (CC) patients.
Developed by researchers at the Moscow Institute of Physics and Technology (MIPT; Russia), the Engelhardt Institute of Molecular Biology (EIMB; Moscow, Russia), and a number of other Russian research centers, the glycochip contains an array of hemispherical hydrogel cells containing immobilized proteins and oligosaccharides that can help detect tumor-associated glycans.
Besides detecting a range of antibodies against glycans (SiaTn, Tn, TF, LeC, LeY, SiaLeA, and Manβ1-4GlcNAcβ), the glycochip also contains antibodies against human immunoglobulins (IgG, IgA, and IgM). The simultaneous measurement of the levels of immunoglobulins in sera enhances the diagnostic impact of the signatures. To test the glycochips, the researchers studied 69 sera samples from healthy donors, 33 from patients with CC, and 27 from patients with inflammatory bowel diseases.
The results showed that the positive predictive value of the test system, based on the diagnostic signatures, allowed it to diagnose CC in 95% of the cases, compared to around 79% detected by traditional methods. The sensitivity of detection (in patients with Stage II-IV CC) was 87%, compared to just 21% by traditional methods. The specificity of the method was 97%. The study was published on March 19, 2016, in Cancer Medicine.
“The method developed at EIMB RAS has great potential to be used in diagnosing gastrointestinal diseases,” said study co-author Zhanna Zubtsova, PhD, an assistant professor in the physics department at MIPT. “We hope that testing systems based on the method will soon appear in clinical laboratories in Russia.”
Glycans are biopolymers consisting of a large number of monosaccharides linked by oxygen atoms. Besides acting as nutrients and building materials for cells, glycans are important for the contact between cells, appropriate organ growth, and much more. Tumor cells hold special glycans that help differentiate them from healthy cells, a key aspect of the new study.
Related Links:
Moscow Institute of Physics and Technology
Engelhardt Institute of Molecular Biology
Developed by researchers at the Moscow Institute of Physics and Technology (MIPT; Russia), the Engelhardt Institute of Molecular Biology (EIMB; Moscow, Russia), and a number of other Russian research centers, the glycochip contains an array of hemispherical hydrogel cells containing immobilized proteins and oligosaccharides that can help detect tumor-associated glycans.
Besides detecting a range of antibodies against glycans (SiaTn, Tn, TF, LeC, LeY, SiaLeA, and Manβ1-4GlcNAcβ), the glycochip also contains antibodies against human immunoglobulins (IgG, IgA, and IgM). The simultaneous measurement of the levels of immunoglobulins in sera enhances the diagnostic impact of the signatures. To test the glycochips, the researchers studied 69 sera samples from healthy donors, 33 from patients with CC, and 27 from patients with inflammatory bowel diseases.
The results showed that the positive predictive value of the test system, based on the diagnostic signatures, allowed it to diagnose CC in 95% of the cases, compared to around 79% detected by traditional methods. The sensitivity of detection (in patients with Stage II-IV CC) was 87%, compared to just 21% by traditional methods. The specificity of the method was 97%. The study was published on March 19, 2016, in Cancer Medicine.
“The method developed at EIMB RAS has great potential to be used in diagnosing gastrointestinal diseases,” said study co-author Zhanna Zubtsova, PhD, an assistant professor in the physics department at MIPT. “We hope that testing systems based on the method will soon appear in clinical laboratories in Russia.”
Glycans are biopolymers consisting of a large number of monosaccharides linked by oxygen atoms. Besides acting as nutrients and building materials for cells, glycans are important for the contact between cells, appropriate organ growth, and much more. Tumor cells hold special glycans that help differentiate them from healthy cells, a key aspect of the new study.
Related Links:
Moscow Institute of Physics and Technology
Engelhardt Institute of Molecular Biology
Latest Critical Care News
- AI to Improved Diagnosis of Atrial Fibrillation
- Stretchable Microneedles to Help In Accurate Tracking of Abnormalities and Identifying Rapid Treatment
- Machine Learning Tool Identifies Rare, Undiagnosed Immune Disorders from Patient EHRs
- On-Skin Wearable Bioelectronic Device Paves Way for Intelligent Implants
- First-Of-Its-Kind Dissolvable Stent to Improve Outcomes for Patients with Severe PAD
- AI Brain-Age Estimation Technology Uses EEG Scans to Screen for Degenerative Diseases
- Wheeze-Counting Wearable Device Monitors Patient's Breathing In Real Time
- Wearable Multiplex Biosensors Could Revolutionize COPD Management
- New Low-Energy Defibrillation Method Controls Cardiac Arrhythmias
- New Machine Learning Models Help Predict Heart Disease Risk in Women
- Deep-Learning Model Predicts Arrhythmia 30 Minutes before Onset
- Breakthrough Technology Combines Detection and Treatment of Nerve-Related Disorders in Single Procedure
- Plasma Irradiation Promotes Faster Bone Healing
- New Device Treats Acute Kidney Injury from Sepsis
- Study Confirms Safety of DCB-Only Strategy for Treating De Novo Left Main Coronary Artery Disease
- Revascularization Improves Quality of Life for Patients with Chronic Limb Threatening Ischemia